Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: US Preventive Services Task Force Recommendation Statement

被引:239
作者
Siu, Albert L. [1 ]
机构
[1] US Prevent Serv Task Force, Rockville, MD USA
关键词
IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; ALL-CAUSE MORTALITY; LOW-DOSE ASPIRIN; FOLLOW-UP; CARDIOVASCULAR OUTCOMES; PRESSURE CONTROL; ADDITION-EUROPE; PEOPLE; TOLERANCE;
D O I
10.7326/M15-2345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. Methods: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. Population: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. Recommendation: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation)
引用
收藏
页码:861 / +
页数:9
相关论文
共 51 条
[1]  
American Academy of Family Physicians, 2008, CLIN PREV SERV REC D
[2]   Introduction [J].
不详 .
DIABETES CARE, 2015, 38 :S1-S2
[3]  
[Anonymous], 2009, National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes
[4]  
[Anonymous], 2014, National diabetes statistics report
[5]   Long-term multiple risk factor interventions in Japanese elderly diabetic patients: The Japanese Elderly Diabetes Intervention Trial - study design, baseline characteristics and effects of intervention [J].
Araki, Atsushi ;
Iimuro, Satoshi ;
Sakurai, Takashi ;
Umegaki, Hiroyuki ;
Iijima, Katsuya ;
Nakano, Hiroshi ;
Oba, Kenzo ;
Yokono, Koichi ;
Sone, Hirohito ;
Yamada, Nobuhiro ;
Ako, Junya ;
Kozaki, Koichi ;
Miura, Hisayuki ;
Kashiwagi, Atsunori ;
Kikkawa, Ryuichi ;
Yoshimura, Yukio ;
Nakano, Tadasumi ;
Ohashi, Yasuo ;
Ito, Hideki .
GERIATRICS & GERONTOLOGY INTERNATIONAL, 2012, 12 :7-17
[6]   Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials [J].
Bangalore, Sripal ;
Kumar, Sunil ;
Lobach, Iryna ;
Messerli, Franz H. .
CIRCULATION, 2011, 123 (24) :2799-+
[7]   Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials [J].
Boussageon, Remy ;
Bejan-Angoulvant, Theodora ;
Saadatian-Elahi, Mitra ;
Lafont, Sandrine ;
Bergeonneau, Claire ;
Kassai, Behrouz ;
Erpeldinger, Sylvie ;
Wright, James M. ;
Gueyffier, Francois ;
Cornu, Catherine .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[8]   Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study [J].
Bray, George A. ;
Edelstein, Sharon L. ;
Crandall, Jill P. ;
Aroda, Vanita R. ;
Franks, Paul W. ;
Fujimoto, Wilfred ;
Horton, Edward ;
Jeffries, Susan ;
Montez, Maria ;
Mudaliar, Sunder ;
Pi-Sunyer, F. Xavier ;
White, Neil H. ;
Knowler, William C. .
DIABETES CARE, 2012, 35 (04) :731-737
[9]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
[10]   Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose - Results of the Diabetes Reduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial [J].
Dagenais, G. R. ;
Gerstein, H. C. ;
Holman, R. ;
Budaj, A. ;
Escalante, A. ;
Hedner, T. ;
Keltai, M. ;
Lonn, E. ;
McFarlane, S. ;
McQueen, M. ;
Teo, K. ;
Sheridan, P. ;
Bosch, J. ;
Pogue, J. ;
Yusuf, S. .
DIABETES CARE, 2008, 31 (05) :1007-1014